Clinical Trial Update: Managing Asthma Patients With AMAZE™: A Novel Disease Management Platform [NA]

View source ↗

Summary

Clinical trial update for AMAZE™, a novel disease management platform, studied in asthma patients. The study is completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AMAZE™

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | NA | Status: COMPLETED | Results posted: 2023-02-08